Αποτελέσματα Αναζήτησης
15 Απρ 2024 · The PREDICT tool uses a combination of day 1 and day 5 variables (cardiac device, community- versus health care-associated versus nosocomial infection, and duration of bacteremia) to identify patients most likely to benefit from TEE .
- Forsblom E, Ruotsalainen E, Ollgren J, Järvinen A. Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in The Management of Staphylococcus Aureus Bacteremia. Clin Infect DIS 2013; 56:527
Crossover was performed after including 15 patients or, at...
- Youngster I, Shenoy Es, Hooper Dc, Nelson Sb. Comparative Evaluation of The Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus Aureus Infections in The Outpatient Setting. Clin Infect Dis 2014; 59:369
Medline ® Abstract for Reference 51 of 'Clinical approach to...
- Thwaites Ge, Scarborough M, Szubert A, Et Al. Adjunctive Rifampicin for Staphylococcus Aureus Bacteraemia (Arrest): a Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. Lancet 2018; 391:668
FINDINGS Between Dec 10, 2012, and Oct 25, 2016, 758...
- Vogel M, Schmitz Rp, Hagel S, Et Al. Infectious Disease Consultation for Staphylococcus Aureus Bacteremia - a Systematic Review and Meta-Analysis. J Infect 2016; 72:19
Medline ® Abstract for Reference 14 of 'Clinical approach to...
- Rasmussen Rv, Høst U, ARPI M, Et Al. Prevalence of Infective Endocarditis in Patients With Staphylococcus Aureus Bacteraemia: The Value of Screening With Echocardiography. EUR J Echocardiogr 2011; 12:414
Medline ® Abstract for Reference 21 of 'Clinical approach to...
- Mylotte Jm, McDermott C, Spooner Ja. Prospective Study of 114 Consecutive Episodes of Staphylococcus Aureus Bacteremia. Rev Infect DIS 1987; 9:891
{{configCtrl2.info.metaDescription}} This site uses cookies....
- Thomas L Holland, MD
Clinical approach to Staphylococcus aureus bacteremia in...
- Khandheria Bk, Seward Jb, Tajik Aj. Transesophageal Echocardiography. Mayo Clin Proc 1994; 69:856
Twenty-one percent were methicillin-resistant Staphylococcus...
- Forsblom E, Ruotsalainen E, Ollgren J, Järvinen A. Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in The Management of Staphylococcus Aureus Bacteremia. Clin Infect DIS 2013; 56:527
17 Ιουλ 2023 · These organisms can grow aerobically or anaerobically (facultative) and at temperatures between 18 C and 40 C. Typical biochemical identification tests include catalase positive (all pathogenic Staphylococcus species), coagulase positive (to distinguish Staphylococcus aureus from other Staphylococcus species), novobiocin sensitive (to ...
Other infections require samples of blood or infected fluids, which are sent to a laboratory to grow (culture), identify, and test the bacteria. Laboratory results confirm the diagnosis and determine which antibiotics can kill the staphylococci (called susceptibility testing).
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections.
Abstract. Staphylococcus aureus is a facultative anaerobic Gram-positive coccus and a member of the normal skin flora as well as the nasal passages of humans. S. aureus is also the etiological agent of suppurative abscesses, as first described by Sir Alexander Ogston in 1880.
1 Σεπ 2005 · The source of infection was identified in 244 series (78.2%). Metastatic infection was detected in 25 bacteremias (8.0%). The mortality rate was 25.6%. The duration of bacteremia (determined in 251 series) was 1–59 days (median duration, 1 day; 70th percentile, 3 days).
Laboratory Studies. Obtain cultures (with susceptibilities) as appropriate for the site of infection. Blood cultures may be positive for staphylococcal species, even when results from other...
